446 filings
Page 15 of 23
424B5
CLLS
Cellectis
6 Apr 18
Prospectus supplement for primary offering
12:00am
CT ORDER
CLLS
Cellectis
5 Apr 18
Confidential treatment order
12:00am
6-K
CLLS
Cellectis
5 Apr 18
Cellectis Announces Pricing of Follow-On Offering
12:00am
6-K
CLLS
Cellectis
4 Apr 18
Cellectis Announces Launch of Follow-On Offering
12:00am
424B5
CLLS
Cellectis
4 Apr 18
Prospectus supplement for primary offering
12:00am
6-K
CLLS
Cellectis
3 Apr 18
Allogene intends to assume from Pfizer the global strategic collaboration agreement originally formed with Cellectis in 2014
12:00am
424B5
CLLS
Cellectis
3 Apr 18
Prospectus supplement for primary offering
12:00am
20-F
2017 FY
CLLS
Cellectis
Annual report (foreign)
13 Mar 18
12:00am
6-K
CLLS
Cellectis
13 Mar 18
Cellectis Reports 4th Quarter and Full Year 2017 Financial Results
12:00am
6-K
CLLS
Cellectis
13 Mar 18
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
8 Mar 18
Cellectis S.a. 6-K
12:00am
SC 13G
CLLS
Cellectis
14 Feb 18
Calyxt, Inc.
12:00am
SC 13G/A
CLLS
Cellectis
13 Feb 18
Cellectis S.A.
12:00am
SC 13G/A
CLLS
Cellectis
13 Feb 18
Cellectis S.A.
12:00am
6-K
CLLS
Cellectis
13 Feb 18
Two Issued U.S. Patents Granted to Cellectis for CRISPR Use in T-Cells
12:00am
6-K
CLLS
Cellectis
9 Jan 18
Current report (foreign)
12:00am
S-8
CLLS
Cellectis
9 Jan 18
Registration of securities for employees
12:00am
6-K
CLLS
Cellectis
13 Dec 17
Cellectis S.a. 6-K
12:00am
6-K
CLLS
Cellectis
4 Dec 17
Cellectis Appoints Elsy Boglioli to Executive Vice President, Strategy and Corporate Development
12:00am
6-K
CLLS
Cellectis
4 Dec 17
Cellectis Appoints Immuno-Oncology Leader Stéphane Depil to Position of Senior Vice President Research & Development and Chief Medical Officer
12:00am